from the United States Court of Appeals for the Federal Circuit
See other cases from the Federal Circuit.
JUDGMENT ISSUED.
Petition GRANTED. Judgment VACATED and case REMANDED for further consideration in light of Bilski v. Kappos, 561 U. S. ___ (2010). (orders list)
Supplemental brief of respondent Merck & Co., Inc. filed. (Distributed)
Supplemental brief of petitioner Classen Immunotherapies, Inc. filed.
Brief of respondent Biogen IDEC in opposition filed.
Response Requested . (Due October 22, 2009)
Waiver of right of respondent Biogen IDEC to respond filed.
Brief of respondent Merck & Co., Inc. in opposition filed.
Brief of respondent GlaxoSmithKline in opposition filed.
Order extending time to file response to petition to and including August 7, 2009, for all respondents.
Petition for a writ of certiorari filed. (Response due July 8, 2009)
Classen Immunotherapies, Inc., Petitioner, represented by Roger Browdy
Classen Immunotherapies, Inc., Petitioner, represented by Joseph J. Zito
Biogen IDEC, Respondent, represented by Noah A. Levine
Biogen IDEC, Respondent, represented by Donald R. Ware
GlaxoSmithKline, Respondent, represented by George F. Pappas
Merck & Co., Inc., Respondent, represented by Mary B. Graham